Aggressive decongestion using high-dose diuretics, ultrafiltration, or inotropes is crucial for managing acute cardiorenal syndrome in acute heart failure.
Supports aggressive decongestion in acute cardiorenal syndrome; leaves open optimal strategies pending randomized trials.
Congestion and acute renal dysfunction are at the center of acute heart failure (HF) syndromes. Acute cardiorenal syndrome, which refers to worsening of renal function in a patient with acute HF syndrome, is partly related to venous congestion and high renal afterload. Aggressive decongestion improves renal and myocardial flow and ventricular loading conditions, potentially resulting in reduced HF progression, rehospitalization, and mortality. High-dose diuretic therapy remains the mainstay therapy. Ultrafiltration and inotropic therapy are useful in the subgroup of patients with a low-output state and diuretic resistance.
No takes yet. Share an insight, caveat, or question.
Hanna et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: